• Black Buffalo

  Participated · Series A · Aug 2022

  Black Buffalo makes smokeless tobacco alternative products that contain pharmaceutical-grade, tobacco-derived nicotine but no tobacco leaf or stem. The company also offers ZERO-branded nicotine-free, tobacco-free products. Its eight core products are the subjects of a bundled PMTA application submitted to the U.S. FDA in September 2020. Products are sold to adult (21+) consumers at over 800 convenience stores and tobacco outlets nationwide and online at blackbuffalo.com. Founded in 2015 and based in Chicago, the company closed a $30M Series A equity round. Black Buffalo intends to use the funds to accelerate every aspect of the business, including hiring in sales, marketing, manufacturing, and finance. Black Buffalo Inc. is a Chicago-based company founded in 2015 that makes smokeless tobacco alternatives. Its product lineup comprises eight SKUs (five long-cut and three pouch varieties) that contain pharmaceutical-grade nicotine but no tobacco leaf or stem. The company says it invested over 20,000 hours of R&D and sells direct-to-consumer online at BlackBuffalo.com to adult consumers age 21 and older. Black Buffalo reported strong sales momentum in 2020, with month-over-month revenue growth of 31% in March and 23% in April. With new capital the company plans to expand marketing, upgrade manufacturing capacity, increase online distribution, and launch into convenience stores and physical retail nationwide. Management is assembling Premarket Tobacco Product Applications for its full portfolio for submission to the FDA and purchased a high-throughput pouch maker expected for Q2 2020 to support demand.

No current team members are available.